Keros Therapeutics Inc (KROS) earnings · rev $243.9M
These earnings events as JSON? API free 100/dayKeros Therapeutics Inc (KROS) is a biotechnology company listed on US.
This KROS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KROS revenue for 2025-12-31 was $243.9M. Net income was $87.0M. KROS currently screens at market cap $208.8M.
When the next KROS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for KROS. We will not invent a beat or miss.
Not investment advice. Full KROS research stays on the stock page; the tape stays on the quote page.
KROS earnings FAQ
What are KROS's latest revenue and net income?
Latest cached Keros Therapeutics Inc (KROS) revenue for Dec 31, 2025 was $243.9M. Net income was $87.0M. Statements: https://lician.com/financials/kros
What is KROS's latest diluted EPS?
Latest cached Keros Therapeutics Inc (KROS) diluted EPS for Dec 31, 2025 was $2.30.
What period does the latest KROS earnings print cover?
The latest cached Keros Therapeutics Inc (KROS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are KROS earnings listed?
Cached earnings facts for Keros Therapeutics Inc (KROS) are listed at https://lician.com/earnings/kros. Statements: https://lician.com/financials/kros
Not investment advice.